CYANOTECH CORP (CYAN)

US2324373016 - Common Stock

0.44  -0.01 (-2.96%)

After market: 0.4499 +0.01 (+2.25%)

Fundamental Rating

1

CYAN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. CYAN has a bad profitability rating. Also its financial health evaluation is rather negative. CYAN has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

CYAN had negative earnings in the past year.
CYAN had a negative operating cash flow in the past year.
In multiple years CYAN reported negative net income over the last 5 years.
In multiple years CYAN reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -16.95%, CYAN is not doing good in the industry: 67.57% of the companies in the same industry are doing better.
CYAN has a Return On Equity (-33.40%) which is in line with its industry peers.
Industry RankSector Rank
ROA -16.95%
ROE -33.4%
ROIC N/A
ROA(3y)-0.63%
ROA(5y)-2.56%
ROE(3y)-1.54%
ROE(5y)-5.26%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of CYAN (29.61%) is worse than 72.97% of its industry peers.
CYAN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CYAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.69%
GM growth 5Y-4.38%

1

2. Health

2.1 Basic Checks

CYAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CYAN has more shares outstanding
The number of shares outstanding for CYAN has been increased compared to 5 years ago.
Compared to 1 year ago, CYAN has a worse debt to assets ratio.

2.2 Solvency

CYAN has an Altman-Z score of -0.42. This is a bad value and indicates that CYAN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.42, CYAN is doing worse than 78.38% of the companies in the same industry.
CYAN has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
CYAN has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -0.42
ROIC/WACCN/A
WACC8.45%

2.3 Liquidity

A Current Ratio of 1.44 indicates that CYAN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.44, CYAN perfoms like the industry average, outperforming 43.24% of the companies in the same industry.
A Quick Ratio of 0.37 indicates that CYAN may have some problems paying its short term obligations.
CYAN has a Quick ratio of 0.37. This is amonst the worse of the industry: CYAN underperforms 89.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.37

0

3. Growth

3.1 Past

The earnings per share for CYAN have decreased strongly by -153.67% in the last year.
The Revenue for CYAN has decreased by -13.23% in the past year. This is quite bad
The Revenue has been decreasing by -7.44% on average over the past years.
EPS 1Y (TTM)-153.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-55.63%
Revenue 1Y (TTM)-13.23%
Revenue growth 3Y-10.1%
Revenue growth 5Y-7.44%
Revenue growth Q2Q-5.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CYAN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CYAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CYANOTECH CORP

NASDAQ:CYAN (2/16/2024, 7:00:01 PM)

After market: 0.4499 +0.01 (+2.25%)

0.44

-0.01 (-2.96%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.03M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.95%
ROE -33.4%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 29.61%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.44
Quick Ratio 0.37
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-153.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.23%
Revenue growth 3Y-10.1%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y